Evidence map›Paper›PMID 41048042›Full record

ReviewTransactions of the Royal Society of Tropical Medicine and Hygiene2026

Chagas disease: host responses, parasite evasion and vaccine advances.

Héctor Serrano-Coll

Abstract readReview
In one paragraph

Review in Transactions of the Royal Society of Tropical Medicine and Hygiene, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Héctor Serrano-CollTropical medicine, Instituto Colombiano de Medicina Tropical-Universidad CES, Cra. 43A #52 Sur - 99, Medellín 055450, Colombia.ORCID 0000-0002-8872-872X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chagas disease is a parasitic infection caused by Trypanosoma cruzi. Although the host immune response has been extensively studied, important knowledge gaps remain, particularly regarding the complex and multifaceted immune evasion mechanisms employed by the parasite, both at the innate and adaptive levels. In recent years, multiple promising vaccine candidates have been developed, but further evaluation is needed across the different phases of clinical trials. Therefore, the aim of this review is to examine the host immune response to T. cruzi, the parasite's immune evasion strategies and recent advances in vaccine development aimed at controlling infection.

Indexed as

Chagas DiseaseHost-Parasite InteractionsImmune EvasionProtozoan VaccinesTrypanosoma cruziAnimalsHumansImmunity, InnateVaccine DevelopmentProtozoan Vaccinesaccess to vaccineimmune evasionimmune responseTrypanosoma cruzivaccine development

Identifiers

PMID41048042
PMCPMC12863075

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.